nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—esophageal cancer	0.485	0.636	CbGaD
Ketorolac—PTGS2—esophageal cancer	0.277	0.364	CbGaD
Ketorolac—PTGS2—Cisplatin—esophageal cancer	0.0763	1	CbGbCtD
Ketorolac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—ALOX15—esophageal cancer	0.00307	0.0724	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—esophageal cancer	0.00138	0.0324	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—ALOX15—esophageal cancer	0.00128	0.0301	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—esophageal cancer	0.00119	0.0281	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FKBP1A—esophageal cancer	0.00112	0.0264	CbGpPWpGaD
Ketorolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—esophageal cancer	0.00108	0.0255	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—esophageal cancer	0.00102	0.0241	CbGpPWpGaD
Ketorolac—PTGS2—Eicosanoid Synthesis—ALOX15—esophageal cancer	0.00101	0.0239	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—PTGS1—esophageal cancer	0.000847	0.0199	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—HMOX1—esophageal cancer	0.000778	0.0183	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.000726	0.0171	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00071	0.0167	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—BAX—esophageal cancer	0.000707	0.0166	CbGpPWpGaD
Ketorolac—PTGS2—Eicosanoid Synthesis—PTGS1—esophageal cancer	0.000702	0.0165	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS1—esophageal cancer	0.000677	0.109	CrCbGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.000668	0.0157	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.000668	0.0157	CbGpPWpGaD
Ketorolac—Nepafenac—PTGS1—esophageal cancer	0.000644	0.103	CrCbGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—esophageal cancer	0.00063	0.0148	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000626	0.0147	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—HMOX1—esophageal cancer	0.000618	0.0146	CbGpPWpGaD
Ketorolac—Fenbufen—PTGS1—esophageal cancer	0.000616	0.0988	CrCbGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.000588	0.0138	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.000576	0.0136	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.000563	0.0133	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—BAX—esophageal cancer	0.000561	0.0132	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CA1—esophageal cancer	0.000551	0.013	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000549	0.0129	CbGpPWpGaD
Ketorolac—Salsalate—PTGS1—esophageal cancer	0.000535	0.0858	CrCbGaD
Ketorolac—Tolmetin—PTGS1—esophageal cancer	0.000535	0.0858	CrCbGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.000531	0.0125	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.000531	0.0125	CbGpPWpGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—esophageal cancer	0.000522	0.0123	CbGpPWpGaD
Ketorolac—Suprofen—PTGS1—esophageal cancer	0.000513	0.0823	CrCbGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.000512	0.0121	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00051	0.012	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—KDR—esophageal cancer	0.000464	0.0109	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—BCL2—esophageal cancer	0.00043	0.0101	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000418	0.00985	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—esophageal cancer	0.000409	0.00963	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00039	0.0092	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS2—esophageal cancer	0.000387	0.0621	CrCbGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000387	0.00911	CbGpPWpGaD
Ketorolac—Nepafenac—PTGS2—esophageal cancer	0.000368	0.059	CrCbGaD
Ketorolac—PTGS2—Spinal Cord Injury—FKBP1A—esophageal cancer	0.000365	0.0086	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000364	0.00856	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.000355	0.00836	CbGpPWpGaD
Ketorolac—Fenbufen—PTGS2—esophageal cancer	0.000352	0.0565	CrCbGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.000345	0.00813	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—BCL2—esophageal cancer	0.000342	0.00805	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—esophageal cancer	0.000339	0.00799	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—ADH7—esophageal cancer	0.000332	0.00783	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000332	0.00782	CbGpPWpGaD
Ketorolac—Tolmetin—PTGS2—esophageal cancer	0.000306	0.0491	CrCbGaD
Ketorolac—Salsalate—PTGS2—esophageal cancer	0.000306	0.0491	CrCbGaD
Ketorolac—Mebendazole—ABCB1—esophageal cancer	0.000293	0.047	CrCbGaD
Ketorolac—Suprofen—PTGS2—esophageal cancer	0.000293	0.047	CrCbGaD
Ketorolac—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000293	0.00261	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000293	0.00261	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000293	0.0069	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—ADH1B—esophageal cancer	0.000291	0.00687	CbGpPWpGaD
Ketorolac—Nasopharyngitis—Capecitabine—esophageal cancer	0.000291	0.00259	CcSEcCtD
Ketorolac—Sepsis—Methotrexate—esophageal cancer	0.00029	0.00258	CcSEcCtD
Ketorolac—Gastritis—Capecitabine—esophageal cancer	0.000288	0.00256	CcSEcCtD
Ketorolac—Eye disorder—Cisplatin—esophageal cancer	0.000286	0.00254	CcSEcCtD
Ketorolac—Tinnitus—Cisplatin—esophageal cancer	0.000285	0.00253	CcSEcCtD
Ketorolac—Lymphadenopathy—Methotrexate—esophageal cancer	0.000284	0.00253	CcSEcCtD
Ketorolac—Flushing—Cisplatin—esophageal cancer	0.000284	0.00252	CcSEcCtD
Ketorolac—Cardiac disorder—Cisplatin—esophageal cancer	0.000284	0.00252	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.000284	0.00668	CbGpPWpGaD
Ketorolac—Abdominal distension—Capecitabine—esophageal cancer	0.000283	0.00252	CcSEcCtD
Ketorolac—Asthma—Capecitabine—esophageal cancer	0.000281	0.0025	CcSEcCtD
Ketorolac—Bronchospasm—Capecitabine—esophageal cancer	0.000277	0.00246	CcSEcCtD
Ketorolac—Photosensitivity—Methotrexate—esophageal cancer	0.000276	0.00246	CcSEcCtD
Ketorolac—Polyuria—Methotrexate—esophageal cancer	0.000276	0.00246	CcSEcCtD
Ketorolac—Immune system disorder—Cisplatin—esophageal cancer	0.000276	0.00246	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000275	0.00649	CbGpPWpGaD
Ketorolac—Mediastinal disorder—Cisplatin—esophageal cancer	0.000275	0.00245	CcSEcCtD
Ketorolac—Sweating increased—Capecitabine—esophageal cancer	0.000274	0.00244	CcSEcCtD
Ketorolac—Arrhythmia—Cisplatin—esophageal cancer	0.000273	0.00243	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP26A1—esophageal cancer	0.000271	0.00638	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—esophageal cancer	0.000271	0.00638	CbGpPWpGaD
Ketorolac—Alopecia—Cisplatin—esophageal cancer	0.00027	0.0024	CcSEcCtD
Ketorolac—Hepatic failure—Methotrexate—esophageal cancer	0.00027	0.0024	CcSEcCtD
Ketorolac—Pancytopenia—Capecitabine—esophageal cancer	0.000267	0.00238	CcSEcCtD
Ketorolac—Malnutrition—Cisplatin—esophageal cancer	0.000266	0.00237	CcSEcCtD
Ketorolac—Erythema—Cisplatin—esophageal cancer	0.000266	0.00237	CcSEcCtD
Ketorolac—Dysuria—Capecitabine—esophageal cancer	0.000263	0.00234	CcSEcCtD
Ketorolac—Renal failure acute—Methotrexate—esophageal cancer	0.000263	0.00234	CcSEcCtD
Ketorolac—Flatulence—Cisplatin—esophageal cancer	0.000262	0.00233	CcSEcCtD
Ketorolac—Ketoprofen—PTGS1—esophageal cancer	0.000261	0.0419	CrCbGaD
Ketorolac—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000257	0.00229	CcSEcCtD
Ketorolac—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000257	0.00229	CcSEcCtD
Ketorolac—Weight increased—Capecitabine—esophageal cancer	0.000256	0.00228	CcSEcCtD
Ketorolac—Visual disturbance—Methotrexate—esophageal cancer	0.000256	0.00228	CcSEcCtD
Ketorolac—Hyperglycaemia—Capecitabine—esophageal cancer	0.000254	0.00226	CcSEcCtD
Ketorolac—Pneumonia—Capecitabine—esophageal cancer	0.000252	0.00225	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTO1—esophageal cancer	0.000252	0.00594	CbGpPWpGaD
Ketorolac—Vision blurred—Cisplatin—esophageal cancer	0.000251	0.00223	CcSEcCtD
Ketorolac—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00025	0.00223	CcSEcCtD
Ketorolac—Tremor—Cisplatin—esophageal cancer	0.000249	0.00222	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000249	0.00221	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000248	0.00585	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000248	0.00585	CbGpPWpGaD
Ketorolac—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000247	0.0022	CcSEcCtD
Ketorolac—Ill-defined disorder—Cisplatin—esophageal cancer	0.000247	0.0022	CcSEcCtD
Ketorolac—Renal failure—Capecitabine—esophageal cancer	0.000247	0.00219	CcSEcCtD
Ketorolac—Myocardial infarction—Capecitabine—esophageal cancer	0.000246	0.00219	CcSEcCtD
Ketorolac—Anaemia—Cisplatin—esophageal cancer	0.000246	0.00219	CcSEcCtD
Ketorolac—Stomatitis—Capecitabine—esophageal cancer	0.000245	0.00218	CcSEcCtD
Ketorolac—Jaundice—Capecitabine—esophageal cancer	0.000245	0.00218	CcSEcCtD
Ketorolac—Conjunctivitis—Capecitabine—esophageal cancer	0.000244	0.00217	CcSEcCtD
Ketorolac—Osteoarthritis—Methotrexate—esophageal cancer	0.000242	0.00216	CcSEcCtD
Ketorolac—Malaise—Cisplatin—esophageal cancer	0.00024	0.00213	CcSEcCtD
Ketorolac—Haematuria—Capecitabine—esophageal cancer	0.000239	0.00213	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—LGALS3—esophageal cancer	0.000239	0.00563	CbGpPWpGaD
Ketorolac—Leukopenia—Cisplatin—esophageal cancer	0.000238	0.00212	CcSEcCtD
Ketorolac—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000237	0.00211	CcSEcCtD
Ketorolac—Epistaxis—Capecitabine—esophageal cancer	0.000237	0.00211	CcSEcCtD
Ketorolac—Agranulocytosis—Capecitabine—esophageal cancer	0.000234	0.00208	CcSEcCtD
Ketorolac—Convulsion—Cisplatin—esophageal cancer	0.000231	0.00205	CcSEcCtD
Ketorolac—Bradycardia—Capecitabine—esophageal cancer	0.000229	0.00204	CcSEcCtD
Ketorolac—Myalgia—Cisplatin—esophageal cancer	0.000226	0.00201	CcSEcCtD
Ketorolac—Haemoglobin—Capecitabine—esophageal cancer	0.000226	0.00201	CcSEcCtD
Ketorolac—Rhinitis—Capecitabine—esophageal cancer	0.000226	0.00201	CcSEcCtD
Ketorolac—Anxiety—Cisplatin—esophageal cancer	0.000226	0.00201	CcSEcCtD
Ketorolac—Haemorrhage—Capecitabine—esophageal cancer	0.000225	0.002	CcSEcCtD
Ketorolac—Hepatitis—Capecitabine—esophageal cancer	0.000225	0.002	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000225	0.002	CcSEcCtD
Ketorolac—Liver function test abnormal—Methotrexate—esophageal cancer	0.000224	0.00199	CcSEcCtD
Ketorolac—Discomfort—Cisplatin—esophageal cancer	0.000224	0.00199	CcSEcCtD
Ketorolac—Urinary tract disorder—Capecitabine—esophageal cancer	0.000222	0.00198	CcSEcCtD
Ketorolac—Connective tissue disorder—Capecitabine—esophageal cancer	0.000221	0.00197	CcSEcCtD
Ketorolac—Urethral disorder—Capecitabine—esophageal cancer	0.000221	0.00196	CcSEcCtD
Ketorolac—Breast disorder—Methotrexate—esophageal cancer	0.000219	0.00195	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000218	0.00194	CcSEcCtD
Ketorolac—Anaphylactic shock—Cisplatin—esophageal cancer	0.000217	0.00193	CcSEcCtD
Ketorolac—Oedema—Cisplatin—esophageal cancer	0.000217	0.00193	CcSEcCtD
Ketorolac—Visual impairment—Capecitabine—esophageal cancer	0.000217	0.00193	CcSEcCtD
Ketorolac—Infection—Cisplatin—esophageal cancer	0.000216	0.00192	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000214	0.00503	CbGpPWpGaD
Ketorolac—Erythema multiforme—Capecitabine—esophageal cancer	0.000213	0.00189	CcSEcCtD
Ketorolac—Nervous system disorder—Cisplatin—esophageal cancer	0.000213	0.00189	CcSEcCtD
Ketorolac—Thrombocytopenia—Cisplatin—esophageal cancer	0.000213	0.00189	CcSEcCtD
Ketorolac—Tachycardia—Cisplatin—esophageal cancer	0.000212	0.00189	CcSEcCtD
Ketorolac—Skin disorder—Cisplatin—esophageal cancer	0.000211	0.00188	CcSEcCtD
Ketorolac—Eye disorder—Capecitabine—esophageal cancer	0.000211	0.00187	CcSEcCtD
Ketorolac—Tinnitus—Capecitabine—esophageal cancer	0.00021	0.00187	CcSEcCtD
Ketorolac—Hyperhidrosis—Cisplatin—esophageal cancer	0.00021	0.00187	CcSEcCtD
Ketorolac—Asthma—Methotrexate—esophageal cancer	0.00021	0.00186	CcSEcCtD
Ketorolac—Flushing—Capecitabine—esophageal cancer	0.000209	0.00186	CcSEcCtD
Ketorolac—Cardiac disorder—Capecitabine—esophageal cancer	0.000209	0.00186	CcSEcCtD
Ketorolac—Eosinophilia—Methotrexate—esophageal cancer	0.000207	0.00185	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL2—esophageal cancer	0.000207	0.00488	CbGpPWpGaD
Ketorolac—Anorexia—Cisplatin—esophageal cancer	0.000207	0.00184	CcSEcCtD
Ketorolac—Pancreatitis—Methotrexate—esophageal cancer	0.000205	0.00183	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—ALDH2—esophageal cancer	0.000205	0.00484	CbGpPWpGaD
Ketorolac—Angiopathy—Capecitabine—esophageal cancer	0.000204	0.00182	CcSEcCtD
Ketorolac—Immune system disorder—Capecitabine—esophageal cancer	0.000203	0.00181	CcSEcCtD
Ketorolac—Mediastinal disorder—Capecitabine—esophageal cancer	0.000203	0.00181	CcSEcCtD
Ketorolac—Hypotension—Cisplatin—esophageal cancer	0.000203	0.0018	CcSEcCtD
Ketorolac—Chills—Capecitabine—esophageal cancer	0.000202	0.0018	CcSEcCtD
Ketorolac—Arrhythmia—Capecitabine—esophageal cancer	0.000201	0.00179	CcSEcCtD
Ketorolac—Alopecia—Capecitabine—esophageal cancer	0.000199	0.00177	CcSEcCtD
Ketorolac—Pancytopenia—Methotrexate—esophageal cancer	0.000199	0.00177	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000198	0.00176	CcSEcCtD
Ketorolac—Mental disorder—Capecitabine—esophageal cancer	0.000197	0.00176	CcSEcCtD
Ketorolac—Erythema—Capecitabine—esophageal cancer	0.000196	0.00174	CcSEcCtD
Ketorolac—Malnutrition—Capecitabine—esophageal cancer	0.000196	0.00174	CcSEcCtD
Ketorolac—Dysuria—Methotrexate—esophageal cancer	0.000196	0.00174	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTT1—esophageal cancer	0.000195	0.0046	CbGpPWpGaD
Ketorolac—Paraesthesia—Cisplatin—esophageal cancer	0.000195	0.00173	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000195	0.00458	CbGpPWpGaD
Ketorolac—Dyspnoea—Cisplatin—esophageal cancer	0.000194	0.00172	CcSEcCtD
Ketorolac—Flatulence—Capecitabine—esophageal cancer	0.000193	0.00172	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP2A6—esophageal cancer	0.000193	0.00455	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000193	0.00454	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—ANXA1—esophageal cancer	0.000193	0.00454	CbGpPWpGaD
Ketorolac—Dysgeusia—Capecitabine—esophageal cancer	0.000192	0.00171	CcSEcCtD
Ketorolac—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000191	0.0017	CcSEcCtD
Ketorolac—Back pain—Capecitabine—esophageal cancer	0.00019	0.00169	CcSEcCtD
Ketorolac—Decreased appetite—Cisplatin—esophageal cancer	0.000189	0.00168	CcSEcCtD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000188	0.00444	CbGpPWpGaD
Ketorolac—Pneumonia—Methotrexate—esophageal cancer	0.000188	0.00167	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000187	0.00167	CcSEcCtD
Ketorolac—Drowsiness—Methotrexate—esophageal cancer	0.000187	0.00166	CcSEcCtD
Ketorolac—Pain—Cisplatin—esophageal cancer	0.000186	0.00165	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000185	0.00165	CcSEcCtD
Ketorolac—Vision blurred—Capecitabine—esophageal cancer	0.000185	0.00164	CcSEcCtD
Ketorolac—Tremor—Capecitabine—esophageal cancer	0.000184	0.00163	CcSEcCtD
Ketorolac—Renal failure—Methotrexate—esophageal cancer	0.000184	0.00163	CcSEcCtD
Ketorolac—Stomatitis—Methotrexate—esophageal cancer	0.000182	0.00162	CcSEcCtD
Ketorolac—Ill-defined disorder—Capecitabine—esophageal cancer	0.000182	0.00162	CcSEcCtD
Ketorolac—Conjunctivitis—Methotrexate—esophageal cancer	0.000182	0.00162	CcSEcCtD
Ketorolac—Anaemia—Capecitabine—esophageal cancer	0.000181	0.00161	CcSEcCtD
Ketorolac—Sweating—Methotrexate—esophageal cancer	0.000179	0.00159	CcSEcCtD
Ketorolac—Feeling abnormal—Cisplatin—esophageal cancer	0.000179	0.00159	CcSEcCtD
Ketorolac—Haematuria—Methotrexate—esophageal cancer	0.000178	0.00158	CcSEcCtD
Ketorolac—Malaise—Capecitabine—esophageal cancer	0.000177	0.00157	CcSEcCtD
Ketorolac—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000177	0.00157	CcSEcCtD
Ketorolac—Epistaxis—Methotrexate—esophageal cancer	0.000176	0.00157	CcSEcCtD
Ketorolac—Vertigo—Capecitabine—esophageal cancer	0.000176	0.00157	CcSEcCtD
Ketorolac—Syncope—Capecitabine—esophageal cancer	0.000176	0.00156	CcSEcCtD
Ketorolac—Leukopenia—Capecitabine—esophageal cancer	0.000176	0.00156	CcSEcCtD
Ketorolac—Agranulocytosis—Methotrexate—esophageal cancer	0.000174	0.00155	CcSEcCtD
Ketorolac—Palpitations—Capecitabine—esophageal cancer	0.000173	0.00154	CcSEcCtD
Ketorolac—Loss of consciousness—Capecitabine—esophageal cancer	0.000172	0.00153	CcSEcCtD
Ketorolac—Body temperature increased—Cisplatin—esophageal cancer	0.000172	0.00153	CcSEcCtD
Ketorolac—Cough—Capecitabine—esophageal cancer	0.000171	0.00152	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000169	0.00399	CbGpPWpGaD
Ketorolac—Hypertension—Capecitabine—esophageal cancer	0.000169	0.00151	CcSEcCtD
Ketorolac—Haemoglobin—Methotrexate—esophageal cancer	0.000169	0.0015	CcSEcCtD
Ketorolac—Haemorrhage—Methotrexate—esophageal cancer	0.000168	0.00149	CcSEcCtD
Ketorolac—Hepatitis—Methotrexate—esophageal cancer	0.000168	0.00149	CcSEcCtD
Ketorolac—Myalgia—Capecitabine—esophageal cancer	0.000167	0.00149	CcSEcCtD
Ketorolac—Arthralgia—Capecitabine—esophageal cancer	0.000167	0.00149	CcSEcCtD
Ketorolac—Chest pain—Capecitabine—esophageal cancer	0.000167	0.00149	CcSEcCtD
Ketorolac—Anxiety—Capecitabine—esophageal cancer	0.000166	0.00148	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000166	0.00148	CcSEcCtD
Ketorolac—Urinary tract disorder—Methotrexate—esophageal cancer	0.000166	0.00147	CcSEcCtD
Ketorolac—Discomfort—Capecitabine—esophageal cancer	0.000165	0.00147	CcSEcCtD
Ketorolac—Urethral disorder—Methotrexate—esophageal cancer	0.000164	0.00146	CcSEcCtD
Ketorolac—Dry mouth—Capecitabine—esophageal cancer	0.000163	0.00145	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—esophageal cancer	0.000162	0.00144	CcSEcCtD
Ketorolac—Confusional state—Capecitabine—esophageal cancer	0.000161	0.00144	CcSEcCtD
Ketorolac—Oedema—Capecitabine—esophageal cancer	0.00016	0.00142	CcSEcCtD
Ketorolac—Hypersensitivity—Cisplatin—esophageal cancer	0.00016	0.00142	CcSEcCtD
Ketorolac—Infection—Capecitabine—esophageal cancer	0.000159	0.00141	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—esophageal cancer	0.000159	0.00141	CcSEcCtD
Ketorolac—Shock—Capecitabine—esophageal cancer	0.000157	0.0014	CcSEcCtD
Ketorolac—Nervous system disorder—Capecitabine—esophageal cancer	0.000157	0.0014	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—esophageal cancer	0.000157	0.00139	CcSEcCtD
Ketorolac—Thrombocytopenia—Capecitabine—esophageal cancer	0.000157	0.00139	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—esophageal cancer	0.000156	0.00139	CcSEcCtD
Ketorolac—Tachycardia—Capecitabine—esophageal cancer	0.000156	0.00139	CcSEcCtD
Ketorolac—Asthenia—Cisplatin—esophageal cancer	0.000156	0.00139	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP1B1—esophageal cancer	0.000156	0.00367	CbGpPWpGaD
Ketorolac—Cardiac disorder—Methotrexate—esophageal cancer	0.000156	0.00138	CcSEcCtD
Ketorolac—Skin disorder—Capecitabine—esophageal cancer	0.000155	0.00138	CcSEcCtD
Ketorolac—Hyperhidrosis—Capecitabine—esophageal cancer	0.000155	0.00138	CcSEcCtD
Ketorolac—Anorexia—Capecitabine—esophageal cancer	0.000153	0.00136	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—esophageal cancer	0.000152	0.00135	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—esophageal cancer	0.000151	0.00135	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—esophageal cancer	0.000151	0.00134	CcSEcCtD
Ketorolac—Chills—Methotrexate—esophageal cancer	0.00015	0.00134	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00015	0.00354	CbGpPWpGaD
Ketorolac—Hypotension—Capecitabine—esophageal cancer	0.00015	0.00133	CcSEcCtD
Ketorolac—Ketoprofen—PTGS2—esophageal cancer	0.000149	0.0239	CrCbGaD
Ketorolac—Diarrhoea—Cisplatin—esophageal cancer	0.000149	0.00132	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—esophageal cancer	0.000148	0.00132	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—esophageal cancer	0.000147	0.00131	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP19A1—esophageal cancer	0.000146	0.00345	CbGpPWpGaD
Ketorolac—Erythema—Methotrexate—esophageal cancer	0.000146	0.0013	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—esophageal cancer	0.000146	0.0013	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000146	0.0013	CcSEcCtD
Ketorolac—Insomnia—Capecitabine—esophageal cancer	0.000145	0.00129	CcSEcCtD
Ketorolac—Paraesthesia—Capecitabine—esophageal cancer	0.000144	0.00128	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—esophageal cancer	0.000143	0.00127	CcSEcCtD
Ketorolac—Dyspnoea—Capecitabine—esophageal cancer	0.000143	0.00127	CcSEcCtD
Ketorolac—Back pain—Methotrexate—esophageal cancer	0.000141	0.00126	CcSEcCtD
Ketorolac—Dyspepsia—Capecitabine—esophageal cancer	0.000141	0.00125	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.00014	0.00329	CbGpPWpGaD
Ketorolac—Decreased appetite—Capecitabine—esophageal cancer	0.000139	0.00124	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000138	0.00123	CcSEcCtD
Ketorolac—Vomiting—Cisplatin—esophageal cancer	0.000138	0.00123	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—esophageal cancer	0.000138	0.00123	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—esophageal cancer	0.000138	0.00122	CcSEcCtD
Ketorolac—Rash—Cisplatin—esophageal cancer	0.000137	0.00122	CcSEcCtD
Ketorolac—Pain—Capecitabine—esophageal cancer	0.000137	0.00122	CcSEcCtD
Ketorolac—Constipation—Capecitabine—esophageal cancer	0.000137	0.00122	CcSEcCtD
Ketorolac—Dermatitis—Cisplatin—esophageal cancer	0.000137	0.00122	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—esophageal cancer	0.000135	0.00121	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—esophageal cancer	0.000135	0.0012	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000133	0.00313	CbGpPWpGaD
Ketorolac—Feeling abnormal—Capecitabine—esophageal cancer	0.000132	0.00117	CcSEcCtD
Ketorolac—Malaise—Methotrexate—esophageal cancer	0.000132	0.00117	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—esophageal cancer	0.000131	0.00117	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000131	0.00309	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000131	0.00116	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—esophageal cancer	0.000131	0.00116	CcSEcCtD
Ketorolac—Nausea—Cisplatin—esophageal cancer	0.000129	0.00115	CcSEcCtD
Ketorolac—Cough—Methotrexate—esophageal cancer	0.000127	0.00113	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—esophageal cancer	0.000127	0.00113	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—esophageal cancer	0.000127	0.00113	CcSEcCtD
Ketorolac—Body temperature increased—Capecitabine—esophageal cancer	0.000127	0.00113	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—esophageal cancer	0.000126	0.00113	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—esophageal cancer	0.000124	0.00111	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—esophageal cancer	0.000124	0.00111	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—esophageal cancer	0.000124	0.00111	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000123	0.0011	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—esophageal cancer	0.000123	0.00109	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000121	0.00284	CbGpPWpGaD
Ketorolac—Confusional state—Methotrexate—esophageal cancer	0.00012	0.00107	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.00012	0.00282	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00012	0.00282	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000119	0.00281	CbGpPWpGaD
Ketorolac—Anaphylactic shock—Methotrexate—esophageal cancer	0.000119	0.00106	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.000118	0.00279	CbGpPWpGaD
Ketorolac—Infection—Methotrexate—esophageal cancer	0.000118	0.00105	CcSEcCtD
Ketorolac—Hypersensitivity—Capecitabine—esophageal cancer	0.000118	0.00105	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—esophageal cancer	0.000117	0.00104	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—esophageal cancer	0.000117	0.00104	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000116	0.00273	CbGpPWpGaD
Ketorolac—Skin disorder—Methotrexate—esophageal cancer	0.000116	0.00103	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—esophageal cancer	0.000115	0.00102	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—esophageal cancer	0.000115	0.00102	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000114	0.00269	CbGpPWpGaD
Ketorolac—Anorexia—Methotrexate—esophageal cancer	0.000114	0.00101	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000113	0.00267	CbGpPWpGaD
Ketorolac—Pruritus—Capecitabine—esophageal cancer	0.000113	0.00101	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—esophageal cancer	0.000111	0.00099	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—esophageal cancer	0.00011	0.000974	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000109	0.000966	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—esophageal cancer	0.000108	0.000959	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	0.000108	0.00254	CbGpPWpGaD
Ketorolac—Paraesthesia—Methotrexate—esophageal cancer	0.000107	0.000952	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—esophageal cancer	0.000106	0.000945	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—esophageal cancer	0.000106	0.000942	CcSEcCtD
Ketorolac—Dizziness—Capecitabine—esophageal cancer	0.000106	0.000942	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000106	0.00249	CbGpPWpGaD
Ketorolac—Dyspepsia—Methotrexate—esophageal cancer	0.000105	0.000933	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	0.000104	0.00245	CbGpPWpGaD
Ketorolac—Decreased appetite—Methotrexate—esophageal cancer	0.000104	0.000921	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000103	0.000915	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—esophageal cancer	0.000103	0.000914	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	0.000102	0.00241	CbGpPWpGaD
Ketorolac—Pain—Methotrexate—esophageal cancer	0.000102	0.000906	CcSEcCtD
Ketorolac—Vomiting—Capecitabine—esophageal cancer	0.000102	0.000905	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000101	0.00239	CbGpPWpGaD
Ketorolac—Rash—Capecitabine—esophageal cancer	0.000101	0.000898	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—esophageal cancer	0.000101	0.000897	CcSEcCtD
Ketorolac—Headache—Capecitabine—esophageal cancer	0.0001	0.000892	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—esophageal cancer	9.82e-05	0.000873	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—esophageal cancer	9.74e-05	0.000867	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	9.66e-05	0.00228	CbGpPWpGaD
Ketorolac—Nausea—Capecitabine—esophageal cancer	9.51e-05	0.000846	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—esophageal cancer	9.47e-05	0.000842	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—esophageal cancer	9.42e-05	0.000838	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—esophageal cancer	9.42e-05	0.000838	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	9.36e-05	0.0022	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	9.36e-05	0.0022	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	9.16e-05	0.00216	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	8.93e-05	0.0021	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8.85e-05	0.00209	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.85e-05	0.00208	CbGpPWpGaD
Ketorolac—Hypersensitivity—Methotrexate—esophageal cancer	8.78e-05	0.000781	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	8.64e-05	0.00203	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—esophageal cancer	8.55e-05	0.000761	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—esophageal cancer	8.43e-05	0.00075	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	8.22e-05	0.00194	CbGpPWpGaD
Ketorolac—Diarrhoea—Methotrexate—esophageal cancer	8.15e-05	0.000725	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.05e-05	0.0019	CbGpPWpGaD
Ketorolac—Dizziness—Methotrexate—esophageal cancer	7.88e-05	0.000701	CcSEcCtD
Ketorolac—PTGS1—Metabolism—BLVRB—esophageal cancer	7.86e-05	0.00185	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC52A3—esophageal cancer	7.86e-05	0.00185	CbGpPWpGaD
Ketorolac—Vomiting—Methotrexate—esophageal cancer	7.58e-05	0.000674	CcSEcCtD
Ketorolac—Rash—Methotrexate—esophageal cancer	7.51e-05	0.000668	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—esophageal cancer	7.51e-05	0.000668	CcSEcCtD
Ketorolac—Headache—Methotrexate—esophageal cancer	7.46e-05	0.000664	CcSEcCtD
Ketorolac—PTGS2—Disease—SLC52A3—esophageal cancer	7.45e-05	0.00176	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	7.16e-05	0.00169	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KMT2D—esophageal cancer	7.11e-05	0.00168	CbGpPWpGaD
Ketorolac—Nausea—Methotrexate—esophageal cancer	7.08e-05	0.00063	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.02e-05	0.00165	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	6.8e-05	0.0016	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC10A2—esophageal cancer	6.69e-05	0.00158	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA1—esophageal cancer	6.69e-05	0.00158	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.28e-05	0.00148	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.25e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BLVRB—esophageal cancer	6.24e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC52A3—esophageal cancer	6.24e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA2—esophageal cancer	6.12e-05	0.00144	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.98e-05	0.00141	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADH7—esophageal cancer	5.69e-05	0.00134	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLCE1—esophageal cancer	5.69e-05	0.00134	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.62e-05	0.00132	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.58e-05	0.00131	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FKBP1A—esophageal cancer	5.51e-05	0.0013	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	5.46e-05	0.00129	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.39e-05	0.00127	CbGpPWpGaD
Ketorolac—PTGS2—Disease—DOCK2—esophageal cancer	5.39e-05	0.00127	CbGpPWpGaD
Ketorolac—PTGS2—Disease—WIF1—esophageal cancer	5.39e-05	0.00127	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	5.34e-05	0.00126	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA1—esophageal cancer	5.31e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC10A2—esophageal cancer	5.31e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.24e-05	0.00123	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADH1B—esophageal cancer	4.99e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CSNK1A1—esophageal cancer	4.97e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA2—esophageal cancer	4.85e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMP—esophageal cancer	4.76e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.74e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP26A1—esophageal cancer	4.63e-05	0.00109	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.63e-05	0.00109	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALOX15—esophageal cancer	4.52e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADH7—esophageal cancer	4.51e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLCE1—esophageal cancer	4.51e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	4.48e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.48e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.46e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTO1—esophageal cancer	4.31e-05	0.00101	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TPI1—esophageal cancer	4.31e-05	0.00101	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.26e-05	0.001	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ELMO1—esophageal cancer	4.18e-05	0.000984	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDOB—esophageal cancer	4.13e-05	0.000973	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GSTO1—esophageal cancer	4.08e-05	0.000962	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TPI1—esophageal cancer	4.08e-05	0.000962	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GAPDH—esophageal cancer	3.98e-05	0.000937	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADH1B—esophageal cancer	3.96e-05	0.000932	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CRABP1—esophageal cancer	3.94e-05	0.000928	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ALDOB—esophageal cancer	3.92e-05	0.000922	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMP—esophageal cancer	3.78e-05	0.000891	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIST1H2BM—esophageal cancer	3.77e-05	0.000888	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GAPDH—esophageal cancer	3.77e-05	0.000888	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GNG7—esophageal cancer	3.75e-05	0.000883	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.71e-05	0.000874	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP26A1—esophageal cancer	3.68e-05	0.000867	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.63e-05	0.000855	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALOX15—esophageal cancer	3.59e-05	0.000845	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDH2—esophageal cancer	3.51e-05	0.000827	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTO1—esophageal cancer	3.42e-05	0.000806	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TPI1—esophageal cancer	3.42e-05	0.000806	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—esophageal cancer	3.34e-05	0.000787	CbGpPWpGaD
Ketorolac—PTGS2—Disease—XIAP—esophageal cancer	3.33e-05	0.000784	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.3e-05	0.000778	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.29e-05	0.000775	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDOB—esophageal cancer	3.28e-05	0.000772	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GAPDH—esophageal cancer	3.16e-05	0.000744	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.15e-05	0.000742	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO1—esophageal cancer	3.13e-05	0.000737	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CRABP1—esophageal cancer	3.13e-05	0.000737	CbGpPWpGaD
Ketorolac—PTGS2—Disease—B2M—esophageal cancer	3.1e-05	0.000729	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSME1—esophageal cancer	3.08e-05	0.000727	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSME2—esophageal cancer	3.08e-05	0.000727	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.05e-05	0.000718	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GNG7—esophageal cancer	2.98e-05	0.000701	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ENO1—esophageal cancer	2.97e-05	0.000699	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSME1—esophageal cancer	2.92e-05	0.000689	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSME2—esophageal cancer	2.92e-05	0.000689	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CALR—esophageal cancer	2.81e-05	0.000661	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH2—esophageal cancer	2.79e-05	0.000657	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FBXW7—esophageal cancer	2.71e-05	0.000639	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.69e-05	0.000635	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.66e-05	0.000627	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—esophageal cancer	2.65e-05	0.000625	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.62e-05	0.000618	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.61e-05	0.000615	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.5e-05	0.00059	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTGS1—esophageal cancer	2.49e-05	0.000585	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO1—esophageal cancer	2.49e-05	0.000585	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSME1—esophageal cancer	2.45e-05	0.000577	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSME2—esophageal cancer	2.45e-05	0.000577	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—esophageal cancer	2.28e-05	0.000538	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.24e-05	0.000528	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFBR2—esophageal cancer	2.19e-05	0.000517	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—esophageal cancer	2.19e-05	0.000516	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.11e-05	0.000498	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMAD4—esophageal cancer	2.08e-05	0.000489	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.99e-05	0.000468	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—esophageal cancer	1.81e-05	0.000427	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.78e-05	0.000419	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCB1—esophageal cancer	1.74e-05	0.00041	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—esophageal cancer	1.7e-05	0.000401	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.66e-05	0.00039	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS2—esophageal cancer	1.55e-05	0.000364	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOTCH1—esophageal cancer	1.53e-05	0.000361	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CREBBP—esophageal cancer	1.46e-05	0.000345	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CREBBP—esophageal cancer	1.39e-05	0.000327	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.32e-05	0.00031	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—esophageal cancer	1.31e-05	0.000309	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—esophageal cancer	1.24e-05	0.000293	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.000283	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CREBBP—esophageal cancer	1.16e-05	0.000274	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—esophageal cancer	1.16e-05	0.000274	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—esophageal cancer	1.04e-05	0.000245	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EP300—esophageal cancer	9.98e-06	0.000235	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—esophageal cancer	9.94e-06	0.000234	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EP300—esophageal cancer	9.46e-06	0.000223	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—esophageal cancer	8.24e-06	0.000194	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—esophageal cancer	8.06e-06	0.00019	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EP300—esophageal cancer	7.92e-06	0.000187	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.38e-06	0.000174	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—esophageal cancer	7e-06	0.000165	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—esophageal cancer	5.86e-06	0.000138	CbGpPWpGaD
